Jim Simons acquired 610k Veracyte shares worth $19.2M. That's 0.02% of their equity portfolio (740th largest holding). The first Veracyte trade was made in Q4 2015. Since then Jim Simons bought shares sixteen more times and sold shares on twelve occasions. The stake costed the investor $17.3M, netting the investor a gain of 11% so far.